Ryan Arthur F

Regeneron Pharmaceuticals Inc · Director

Ryan Arthur F is listed in filings as Director at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Sep 5, 2024 to May 4, 2026. Reported amounts are shown as $4.9K to $3.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Regeneron Pharmaceuticals IncREGN$6.3k6 sharesSellOct 1, 2024$1,050.60$627.74
Regeneron Pharmaceuticals IncREGN$5.2k5 sharesSellOct 1, 2024$1,043.39$627.74
Regeneron Pharmaceuticals IncREGN$4.8k4 sharesSellSep 3, 2024$1,191.02$627.74
Regeneron Pharmaceuticals IncREGN$4.8k4 sharesSellSep 3, 2024$1,188.55$627.74
Regeneron Pharmaceuticals IncREGN$4.7k4 sharesSellSep 3, 2024$1,185.77$627.74
Regeneron Pharmaceuticals IncREGN$4.7k4 sharesSellSep 3, 2024$1,178.69$627.74
Regeneron Pharmaceuticals IncREGN$4.7k4 sharesSellSep 3, 2024$1,177.73$627.74
Regeneron Pharmaceuticals IncREGN$19k16 sharesSellSep 3, 2024$1,172.75$627.74
Regeneron Pharmaceuticals IncREGN$9.5k8 sharesSellSep 3, 2024$1,183.47$627.74
Regeneron Pharmaceuticals IncREGN$9.4k8 sharesSellSep 3, 2024$1,179.62$627.74
Regeneron Pharmaceuticals IncREGN$9.4k8 sharesSellSep 3, 2024$1,175.66$627.74
Regeneron Pharmaceuticals IncREGN$9.4k8 sharesSellSep 3, 2024$1,174.32$627.74
Regeneron Pharmaceuticals IncREGN$5.9k5 sharesSellSep 3, 2024$1,189.13$627.74
Regeneron Pharmaceuticals IncREGN$5.9k5 sharesSellSep 3, 2024$1,186.19$627.74
Showing 51-64 of 64